306 related articles for article (PubMed ID: 9083481)
61. HIV-1 integrase inhibitors: 2007-2008 update.
Ramkumar K; Serrao E; Odde S; Neamati N
Med Res Rev; 2010 Nov; 30(6):890-954. PubMed ID: 20135632
[TBL] [Abstract][Full Text] [Related]
62. Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors.
Rajamaki S; Innitzer A; Falciani C; Tintori C; Christ F; Witvrouw M; Debyser Z; Massa S; Botta M
Bioorg Med Chem Lett; 2009 Jul; 19(13):3615-8. PubMed ID: 19447621
[TBL] [Abstract][Full Text] [Related]
63. Synthesis of polyhydroxylated aromatics having amidation of piperazine nitrogen as HIV-1 integrase inhibitor.
Yang L; Xu X; Huang Y; Zhang B; Zeng C; He H; Wang C; Hu L
Bioorg Med Chem Lett; 2010 Sep; 20(18):5469-71. PubMed ID: 20709544
[TBL] [Abstract][Full Text] [Related]
64. Design and synthesis of novel indole beta-diketo acid derivatives as HIV-1 integrase inhibitors.
Sechi M; Derudas M; Dallocchio R; Dessì A; Bacchi A; Sannia L; Carta F; Palomba M; Ragab O; Chan C; Shoemaker R; Sei S; Dayam R; Neamati N
J Med Chem; 2004 Oct; 47(21):5298-310. PubMed ID: 15456274
[TBL] [Abstract][Full Text] [Related]
65. Implications of HIV-1 M group polymorphisms on integrase inhibitor efficacy and resistance: genetic and structural in silico analyses.
Loizidou EZ; Kousiappa I; Zeinalipour-Yazdi CD; Van de Vijver DA; Kostrikis LG
Biochemistry; 2009 Jan; 48(1):4-6. PubMed ID: 19090674
[TBL] [Abstract][Full Text] [Related]
66. Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase.
Melamed JY; Egbertson MS; Varga S; Vacca JP; Moyer G; Gabryelski L; Felock PJ; Stillmock KA; Witmer MV; Schleif W; Hazuda DJ; Leonard Y; Jin L; Ellis JD; Young SD
Bioorg Med Chem Lett; 2008 Oct; 18(19):5307-10. PubMed ID: 18774711
[TBL] [Abstract][Full Text] [Related]
67. Application of CoMFA and CoMSIA 3D-QSAR and docking studies in optimization of mercaptobenzenesulfonamides as HIV-1 integrase inhibitors.
Kuo CL; Assefa H; Kamath S; Brzozowski Z; Slawinski J; Saczewski F; Buolamwini JK; Neamati N
J Med Chem; 2004 Jan; 47(2):385-99. PubMed ID: 14711310
[TBL] [Abstract][Full Text] [Related]
68. From ligand to complexes. Part 2. Remarks on human immunodeficiency virus type 1 integrase inhibition by beta-diketo acid metal complexes.
Bacchi A; Biemmi M; Carcelli M; Carta F; Compari C; Fisicaro E; Rogolino D; Sechi M; Sippel M; Sotriffer CA; Sanchez TW; Neamati N
J Med Chem; 2008 Nov; 51(22):7253-64. PubMed ID: 18983138
[TBL] [Abstract][Full Text] [Related]
69. Investigation of the structural requirement for inhibiting HIV integrase: QSAR study.
Dessalew N
Acta Pharm; 2009 Mar; 59(1):31-43. PubMed ID: 19304556
[TBL] [Abstract][Full Text] [Related]
70. Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazoles.
Middleton T; Lim HB; Montgomery D; Rockway T; Tang H; Cheng X; Lu L; Mo H; Kohlbrenner WE; Molla A; Kati WM
Antiviral Res; 2004 Oct; 64(1):35-45. PubMed ID: 15451177
[TBL] [Abstract][Full Text] [Related]
71. HIV integrase as a target for antiviral chemotherapy.
Nair V
Rev Med Virol; 2002; 12(3):179-93. PubMed ID: 11987143
[TBL] [Abstract][Full Text] [Related]
72. Discovery of novel, non-peptide HIV-1 protease inhibitors by pharmacophore searching.
Wang S; Milne GW; Yan X; Posey IJ; Nicklaus MC; Graham L; Rice WG
J Med Chem; 1996 May; 39(10):2047-54. PubMed ID: 8642563
[TBL] [Abstract][Full Text] [Related]
73. Identification of novel HIV-1 integrase inhibitors using shape-based screening, QSAR, and docking approach.
Gupta P; Garg P; Roy N
Chem Biol Drug Des; 2012 May; 79(5):835-49. PubMed ID: 22233531
[TBL] [Abstract][Full Text] [Related]
74. New chloro,fluorobenzylindole derivatives as integrase strand-transfer inhibitors (INSTIs) and their mode of action.
Ferro S; De Luca L; Barreca ML; De Grazia S; Christ F; Debyser Z; Chimirri A
Bioorg Med Chem; 2010 Aug; 18(15):5510-8. PubMed ID: 20630765
[TBL] [Abstract][Full Text] [Related]
75. Development of a receptor model for efficient in silico screening of HIV-1 integrase inhibitors.
Quevedo MA; Ribone SR; Briñón MC; Dehaen W
J Mol Graph Model; 2014 Jul; 52():82-90. PubMed ID: 25023663
[TBL] [Abstract][Full Text] [Related]
76. QSAR study of carboxylic acid derivatives as HIV-1 Integrase inhibitors.
Cheng Z; Zhang Y; Fu W
Eur J Med Chem; 2010 Sep; 45(9):3970-80. PubMed ID: 20561721
[TBL] [Abstract][Full Text] [Related]
77. Discovery of a novel HIV-1 integrase inhibitor from natural compounds through structure based virtual screening and cell imaging.
Gu WG; Zhang X; Ip DT; Yang LM; Zheng YT; Wan DC
FEBS Lett; 2014 Sep; 588(18):3461-8. PubMed ID: 25128456
[TBL] [Abstract][Full Text] [Related]
78. N-hydroxy-substituted 2-aryl acetamide analogs: A novel class of HIV-1 integrase inhibitors.
Debnath U; Kumar P; Agarwal A; Kesharwani A; Gupta SK; Katti SB
Chem Biol Drug Des; 2017 Oct; 90(4):527-534. PubMed ID: 28294572
[TBL] [Abstract][Full Text] [Related]
79. Combined ligand and structure-based approaches on HIV-1 integrase strand transfer inhibitors.
Reddy KK; Singh SK
Chem Biol Interact; 2014 Jul; 218():71-81. PubMed ID: 24792351
[TBL] [Abstract][Full Text] [Related]
80. 2-hydroxyisoquinoline-1,3(2H,4H)-diones as inhibitors of HIV-1 integrase and reverse transcriptase RNase H domain: influence of the alkylation of position 4.
Billamboz M; Bailly F; Lion C; Calmels C; Andréola ML; Witvrouw M; Christ F; Debyser Z; De Luca L; Chimirri A; Cotelle P
Eur J Med Chem; 2011 Feb; 46(2):535-46. PubMed ID: 21185110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]